Sophia Faulkner

Sophia Faulkner is a Researcher in the Department of Internal Medicine at Yale School of Medicine. She holds a BA in Economics from the University of California, Berkeley. Her research focuses on kidney diseases, including lupus nephritis, acute kidney injury, and pediatric chronic kidney conditions. Collaborations include studies on clinical protocols for hospitalized patients and the long-term renal impacts of COVID-19. Her work appears in high-impact journals like JAMA and Pediatric Nephrology. She is part of a multidisciplinary team investigating biomarkers and molecular mechanisms in kidney pathology.

Education: BA in Economics (University of California, Berkeley). Research interests emphasize translational nephrology, clinical outcomes research, and immunology's role in kidney disease. Active in collaborative projects addressing acute and chronic kidney conditions, particularly leveraging molecular tools like DNA methylation analysis.

Her studies often involve large-scale patient cohorts and interdisciplinary teams. Notable contributions include analyzing post-pandemic kidney outcomes and biomarker discovery in pediatric populations.